This metabolic support may actually benefit your recovery in some cases, though your specific situation depends on your baseline health, diabetes status, and infection severity
For those taking insulin or sulfonylureas, this may increase hypoglycaemia risk, requiring medication review
Because if we're going to take them, we need to understand not just what they can do to help, but where they may harm us and how we can address that to ensure we stay healthy and get the best results
The FDA's Pharmacy Compounding Advisory Committee will meet on Wednesday and Thursday to consider if seven peptides should be added to the agency's 503A Bulks List, a step that would permit state-licensed compounding pharmacies to prepare the substances for patients with prescriptions
Compounded tirzepatide remains under FDA scrutiny
Older adults and those with coronary disease typically require lower doses